Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Case Reports

Research Support, Non-U.S. Gov't

Observational Study

Multicenter Study

Comparative Study

Clinical Trial

Randomized Controlled Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2026

2025

2024

2018

2017

2016

2012

2007

2006

2005

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Hypertension, Malignant""[mesh_terms]

15 Results

Searching titles within these results

Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension.

Tanja Dudenbostel, David A Calhoun

American journal of hypertension 2018;30(2):103-109

Free Full Text

Abstract

An ectopic renin-secreting adrenal corticoadenoma in a child with malignant hypertension.

Janos Peti-Peterdi, Josephine HaDuong, Rajkumar Venkatramani, Christopher P Gayer, Nick Shillingford, Abraham M Kaslow, Anne Riquier-Brison

Physiological reports 2016;4(5):e12728

Free Full Text

Abstract

Brain Natriuretic Peptide Counteracting the Renin-angiotensin-aldosterone System in Accelerated Malignant Hypertension.

Hitoshi Nakagawa, Yuji Mizuno, Eisaku Harada, Yoshinobu Morikawa, Koichiro Kuwahara, Yoshihiko Saito, Hirofumi Yasue

The American journal of the medical sciences 2017;352(5):534-539

Full Text

Abstract

Management of hypertensive crises.

Carlos Feldstein

American journal of therapeutics 2007;14(2):135-9

Full Text

Abstract

From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency.

A Cremer, F Amraoui, G Y H Lip, E Morales, S Rubin, J Segura, B J Van den Born, P Gosse

Journal of human hypertension 2018;30(8):463-6

Full Text

Abstract

Baseline characteristics of the first 302 patients included for acute malignant hypertension crisis in the prospective multidisciplinary HAMA cohort.

Jean Michel Halimi, Alexandre Persu, Mikael Mazighi, Pierre-Louis Tharaux, Antoine Cremer, Michel Paques, Aurélien Lorthioir, Sophie Bonnin, Philippe Gosse, Stéphane Debeugny, Alice Seris, Benjamin Maier, Hervé Dreau, Romain Boulestreau, Sébastien Rubin

Journal of hypertension 2024;42(12):2131-2138

Full Text

Abstract

The transdermal delivery system of monoamine oxidase inhibitors.

Chad M VanDenBerg

The Journal of clinical psychiatry 2012;73 Suppl 1():25-30

Free Full Text

Abstract

Angiotensin receptor-neprilysin inhibitor in the management of heart failure in patients with an episode of malignant hypertension and advanced kidney dysfunction: A case series and literature review.

Masahide Mizobuchi, Hirokazu Honda, Tomohiro Saito, Mitsuru Kawanishi, Kazuki Abe, Yuki Kajio, Risa Samejima, Yuuki Mima

Clinical nephrology 2025;104(3):218-225

Full Text

Abstract

Malignant Hypertension Revisited-Does This Still Exist?

Alena Shantsila, Gregory Y H Lip

American journal of hypertension 2018;30(6):543-549

Full Text

Abstract

Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.

David A Flockhart

The Journal of clinical psychiatry 2012;73 Suppl 1():17-24

Free Full Text

Abstract

Hypertensive crisis: hypertensive emergencies and urgencies.

Ijaz A Khan, Monica Aggarwal

Cardiology clinics 2006;24(1):135-46

Full Text

Abstract

Pheochromocytoma: a paradigm for catecholamine-mediated hypertension.

D Maiter

Acta clinica Belgica 2005;59(4):209-19

Full Text

Abstract

Long-term renal outcomes of patients with biopsy-proven malignant hypertension-associated renal thrombotic microangiopathy who are dialysis-independent at baseline.

Jianbo Li, Youqi Li, Zhong Zhong, Zefang Dai, Naya Huang, Jianwen Yu, Xuwen Shen, Shicong Yang, Qinghua Liu, Wei Chen

Renal failure 2026;48(1):2617722

Free Full Text

Abstract

The use of monoamine oxidase inhibitors in primary care.

Larry Culpepper

The Journal of clinical psychiatry 2012;73 Suppl 1():37-41

Free Full Text

Abstract

Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.

J A Tumlin, L M Dunbar, S Oparil, V Buckalew, C V Ram, V Mathur, D Ellis, D McGuire, J Fellmann, R R Luther

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2000;7(6):653-62

Free Full Text

Abstract

Results: 1 – 15 / 15

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Hypertension, Malignant""[mesh_terms]

Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension.

An ectopic renin-secreting adrenal corticoadenoma in a child with malignant hypertension.

Brain Natriuretic Peptide Counteracting the Renin-angiotensin-aldosterone System in Accelerated Malignant Hypertension.

Management of hypertensive crises.

From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency.

Baseline characteristics of the first 302 patients included for acute malignant hypertension crisis in the prospective multidisciplinary HAMA cohort.

The transdermal delivery system of monoamine oxidase inhibitors.

Angiotensin receptor-neprilysin inhibitor in the management of heart failure in patients with an episode of malignant hypertension and advanced kidney dysfunction: A case series and literature review.

Malignant Hypertension Revisited-Does This Still Exist?

Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.

Hypertensive crisis: hypertensive emergencies and urgencies.

Pheochromocytoma: a paradigm for catecholamine-mediated hypertension.

Long-term renal outcomes of patients with biopsy-proven malignant hypertension-associated renal thrombotic microangiopathy who are dialysis-independent at baseline.

The use of monoamine oxidase inhibitors in primary care.

Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.

Results for
""Hypertension, Malignant""[mesh_terms]